在接受非小细胞癌治疗后,炎症性肌纤维细胞瘤
Neil C Parker1, Prashanth Singanallur2, Saif Faiek3
1Internal Medicine, Southern Illinois University School of Medicine, Springfield, USA.
Cureus
|May 31, 2024
概括
本案例研究突出了一个极为罕见的成年炎性肌纤维细胞瘤 (IMT) 在一个63岁的女性. 该研究详细介绍了这种不寻常的疾病的诊断挑战和临床演变.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 炎症性伪瘤是一种带有状细胞增殖和炎症的疾病谱.
- 炎症性肌纤维细胞瘤 (IMT) 是这一谱内的一个独特的实体,在成年人中很少见,通常影响年轻人群.
- 成人IMT,特别是在肺部,是非常罕见的,占成年肺部瘤的不到1%.
研究的目的:
- 在成年女性患者中呈现一种罕见的炎症性肌纤维细胞瘤 (IMT) 病例.
- 讨论IMT的诊断复杂性和临床表现,在患有重大并发症和先前癌症治疗的患者的背景下.
主要方法:
- 病例报告详细介绍了一名63岁的女性患者的临床病史,诊断工作和治疗.
- 对炎症性肌纤维细胞瘤 (IMT) 的病理和临床特征的审查,特别是在成年人群中.
主要成果:
- 这位患有慢性肺炎史且先前接受过非小细胞肺癌治疗的患者患有快速发展的炎症性肌纤维细胞瘤 (IMT).
- 该病例提出了诊断挑战,因为它在成年人中很少见,并且患者的医疗背景复杂.
结论:
- 炎症性肌纤维细胞瘤 (IMT) 可能发生在成年人身上,这给诊断和治疗带来了挑战.
- 这一案例强调了在有复杂病史的成人患者中考虑IMT的重要性,即使在癌症治疗后也是如此.
更多相关视频
11:31Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
Published on: May 20, 2016
10.7K
07:15A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
9.6K
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
